<DOC>
	<DOC>NCT01397812</DOC>
	<brief_summary>The purpose of this study is to demonstrate and validate a breath test for detection of biomarkers of heart transplant rejection (Grade 2R heart transplant).</brief_summary>
	<brief_title>Heartsbreath Test for Heart Transplant Rejection</brief_title>
	<detailed_description>This is a 36 month multi-center, open label, unblinded and blinded study on subjects have had a heart transplant within the previous 12 months and are scheduled to undergo an endomyocardial biopsy. The breath test will be performed to identify and validate the predicative algorithms that identify breath biomarkers for heart transplant rejection.</detailed_description>
	<criteria>Subject is willing and able to cooperate with study, understand the scope of the study, and gives signed informed consent to participate. Subject is the recipient of a heart transplant within the previous 12 months Subject is scheduled for a routine endomyocardial biopsy Subject is 18 years or older Evidence of acute intercurrent disease other than rejection reaction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Rejection of the Heart Transplant</keyword>
	<keyword>Heart Transplant Rejection, an immune-mediated allograft injury</keyword>
	<keyword>Non-cellular or humoral rejection in cardiac transplant recipients</keyword>
	<keyword>Right ventricular endomyocardial biopsy to detect Heart transplant rejection</keyword>
</DOC>